43 results
8-K
EX-3.1
PRME
Prime Medicine Inc
21 May 24
Amendments to Articles of Incorporation or Bylaws
4:03pm
by or in the manner designated by the Board of Directors or a committee thereof to which the Board of Directors has delegated such responsibility.
SECTION 2
PRE 14A
PRME
Prime Medicine Inc
19 Apr 24
Preliminary proxy
4:07pm
Rhythm after 16 years at Merck Research Laboratories, where he held positions of increasing responsibility, including serving as a leader of Merck’s … to May 2016, Mr. Brudnick worked at Biogen Inc., a biotechnology company, where he held positions of increasing responsibility, including serving
8-K
EX-1.1
6jna4h3 77qpt9z
16 Feb 24
Entry into a Material Definitive Agreement
6:23am
424B5
94rgv2dse7 87sokd
16 Feb 24
Prospectus supplement for primary offering
6:17am
424B5
yatjstmsgn nbrkghb
14 Feb 24
Prospectus supplement for primary offering
5:27pm
8-K
hz1b 3gep8mu7ei6
14 Feb 24
Results of Operations and Financial Condition
4:12pm
S-3
EX-4.5
azc9 9683dml8
3 Nov 23
Shelf registration
5:23pm
S-3
EX-1.2
tjjlkw up
3 Nov 23
Shelf registration
5:23pm
S-3
mgr no8a9h71djo
3 Nov 23
Shelf registration
5:23pm
S-3
EX-4.6
sjvbv
3 Nov 23
Shelf registration
5:23pm
DEF 14A
tectl4 mj
28 Apr 23
Definitive proxy
8:34am
10-Q
5fc59
14 Nov 22
Quarterly report
4:46pm
424B4
d2u08v qdifqoyi8
21 Oct 22
Prospectus supplement with pricing info
4:47pm